Skip to main content
Premium Trial:

Request an Annual Quote

Barclays Upgrades Agilent, Downgrades Bruker

NEW YORK (GenomeWeb) – Investment bank Barclays has upgraded shares of Agilent to Overweight from Equal Weight and downgraded shares of Bruker to Equal Weight from Overweight.

In a research note, analyst Jack Meehan wrote that Agilent's strength in biopharma and a new gas chromatography product cycle are signs "boding well for improved growth." He cited positive trends in the biopharma end market, which accounted for 30 percent of the firm's revenues and 15 percent of growth in fiscal year 2016. Cash repatriation opportunities also contributed to the upgrade. Barclays set a new price target for shares of Agilent at $51, up from $48.

He downgraded Bruker due to a "more cautious outlook on European academic exposure," with a price target of $22, down from $30; however, he raised the EPS estimate for Fiscal Year 2017 to $1.10, up from $1.09. "We have limited visibility into when the academic end market will begin to improve in Europe, where Bruker has outsized exposure relative to peers," Meehan wrote. Still, he said that Bruker continued to be a big turnaround story in life science tools.

Meehan also reiterated Overweight ratings for shares of Hologic, Qiagen, Quidel, and Laboratory Corporation of America.

The note covered Barclays' outlook for the US Life Science tools and diagnostics sector. Meehan said he expected the coverage group to be "in line with the broader market," affected by lingering uncertainty in diagnostics reimbursement and a stronger US dollar bringing foreign exchange headwinds.

Barclays added that shares of Thermo Fisher Scientific remained a "top pick."

In afternoon trading on the New York Stock Exchange, shares of Agilent were up more than 1 percent at $47.10, while on the Nasdaq, shares of Bruker were up less than one percent at $21.74.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.